Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Tuberculosis Prevention and Treatment Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

According to our (Global Info Research) latest study, the global Tuberculosis Prevention and Treatment Vaccine market size was valued at USD 76 million in 2023 and is forecast to a readjusted size of USD 102.9 million by 2030 with a CAGR of 4.4% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Tuberculosis Prevention and Treatment Vaccine Supply, Demand and Key Producers, 2023-2029

date 25 Feb 2023

date Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2029, rising at a market growth of 4.4% CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Tuberculosis Prevention and Treatment Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

USD3480.00

Add To Cart

Add To Cart

industry 18 Feb 2024

industry Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 09 Jan 2024

industry Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

According to our (Global Info Research) latest study, the global Tuberculosis Prevention and Treatment Vaccine market size was valued at USD 76 million in 2023 and is forecast to a readjusted size of USD 102.9 million by 2030 with a CAGR of 4.4% during review period.

USD3480.00

addToCart

Add To Cart

industry 25 Feb 2023

industry Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

The global Tuberculosis Prevention and Treatment Vaccine market size is expected to reach $ 102.9 million by 2029, rising at a market growth of 4.4% CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 09 Jan 2023

industry Pharma & Healthcare

new_biaoQian Tuberculosis Prevention and Treatment Vaccine

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

USD3480.00

addToCart

Add To Cart